Nucleic acid vaccines: research tool or commercial reality
- 1 August 2000
- journal article
- review article
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 76 (1-2) , 1-23
- https://doi.org/10.1016/s0165-2427(00)00198-7
Abstract
No abstract availableKeywords
This publication has 128 references indexed in Scilit:
- A strategy to improve the efficacy of vaccination against tuberculosis and leprosyPublished by Elsevier ,2003
- Antibody and cellular immune responses of swine following immunisation with plasmid DNA encoding the PRRS virus ORF’s 4, 5, 6 and 7Research in Veterinary Science, 1999
- Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigsVeterinary Immunology and Immunopathology, 1998
- Immunogenicity of Vector DNA Vaccine Constructs of Pseudorabies Virus Immediate Early Gene (IE180) in Mice and SwineaAnnals of the New York Academy of Sciences, 1998
- Depth-Targeted Efficient Gene Delivery and Expression in the Skin by Pulsed Electric Fields: An Approach to Gene Therapy of Skin Aging and Other DiseasesBiochemical and Biophysical Research Communications, 1996
- The Third Vaccine RevolutionNature Biotechnology, 1995
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Establishment of Stable, Cell-Mediated Immunity that Makes "Susceptible" Mice Resistant to Leishmania majorScience, 1992
- Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.The Journal of Experimental Medicine, 1987
- The adjuvant effects of mycoviral dsRNA and polyinosinic:polycytidylic acid on the murine immune responseBiochemical and Biophysical Research Communications, 1985